IL4 receptor α mediates enhanced glucose and glutamine metabolism to support breast cancer growth

Biochimica et Biophysica Acta - Molecular Cell Research

Volumn 1853, Issue 5, 2015, Pages 1219-1228

  Venmar, Katherine T ^a   Kimmel, Danielle W ^b   Cliffel, David E ^b   Fingleton, Barbara ^a  

^a VANDERBILT UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b VANDERBILT UNIVERSITY   (United States)

Author keywords

Cytokine; Glucose; Metabolism; Proliferation; Survival

Indexed keywords

GLUCOSE; GLUCOSE TRANSPORTER 1; GLUTAMINE; INTERLEUKIN 4 RECEPTOR ALPHA; LACTIC ACID; CARRIER PROTEIN; INTERLEUKIN 4; INTERLEUKIN 4 RECEPTOR;

AMINO ACID METABOLISM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST CANCER; BREAST CANCER CELL LINE; CANCER GROWTH; CELL COUNT; CELL PROLIFERATION; CONTROLLED STUDY; GLUCOSE INTAKE; GLUCOSE METABOLISM; GLUTAMINE METABOLISM; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; ANIMAL; BREAST TUMOR; DRUG EFFECTS; EXPERIMENTAL MAMMARY NEOPLASM; FEMALE; METABOLISM; PATHOLOGY; TUMOR CELL LINE;

MURINAE;

ANIMALS; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL PROLIFERATION; FEMALE; GLUCOSE; GLUCOSE TRANSPORTER TYPE 1; GLUTAMINE; HUMANS; INTERLEUKIN-4; MAMMARY NEOPLASMS, ANIMAL; MEMBRANE TRANSPORT PROTEINS; MICE; RECEPTORS, INTERLEUKIN-4;

EID: 84924709550     PISSN: 01674889     EISSN: 18792596     Source Type: Journal    
DOI: 10.1016/j.bbamcr.2015.02.020     Document Type: Article

References (40)

1. Cancer Facts and Figures 2013, American Cancer Society, Atlanta, 2013.
2. Ben-Baruch A. Host microenvironment in breast cancer development: inflammatory cells, cytokines and chemokines in breast cancer progression: reciprocal tumor-microenvironment interactions. Breast Cancer Res. 2003, 5:31-36.
3. Nelms K., Keegan A.D., Zamorano J., Ryan J.J., Paul W.E. The IL-4 receptor: signaling mechanisms and biologic functions. Annu. Rev. Immunol. 1999, 17:701-738.
4. Todaro M., Lombardo Y., Francipane M.G., Alea M.P., Cammareri P., Iovino F., et al. Apoptosis resistance in epithelial tumors is mediated by tumor-cell-derived interleukin-4. Cell Death Differ. 2008, 15:762-772.
5. LaPorte S.L., Juo Z.S., Vaclavikova J., Colf L.A., Qi X., Heller N.M., et al. Molecular and structural basis of cytokine receptor pleiotropy in the interleukin-4/13 system. Cell 2008, 132:259-272.
6. Camp B.J., Dyhrman S.T., Memoli V.A., Mott L.A., Barth R.J. In situ cytokine production by breast cancer tumor-infiltrating lymphocytes. Ann. Surg. Oncol. 1996, 3:176-184.
7. Venmar K.T., Carter K.J., Hwang D.G., Dozier E.A., Fingleton B. IL-4 receptor ILR4α regulates metastatic colonization by mammary tumors through multiple signaling pathways. Cancer Res. 2014, 74:4329-4340.
8. Dufort F.J., Bleiman B.F., Gumina M.R., Blair D., Wagner D.J., Roberts M.F., et al. Cutting edge: IL-4-mediated protection of primary B lymphocytes from apoptosis via Stat6-dependent regulation of glycolytic metabolism. J. Immunol. 2007, 179:4953-4957.
9. Wang R., Green D.R. Metabolic checkpoints in activated T cells. Nat. Immunol. 2012, 13:907-915.
10. Or R., Renz H., Terada N., Gelfand E.W. IL-4 and IL-2 promote human T-cell proliferation through symmetrical but independent pathways. Clin. Immunol. Immunopathol. 1992, 64:210-217.
11. Cho S.H., Ahn A.K., Bhargava P., Lee C.-H., Eischen C.M., McGuinness O., et al. Glycolytic rate and lymphomagenesis depend on PARP14, an ADP ribosyltransferase of the B aggressive lymphoma (BAL) family. Proc. Natl. Acad. Sci. U. S. A. 2011, 108:15972-15977.
12. Kroemer G., Pouyssegur J. Tumor cell metabolism: cancer's Achilles' heel. Cancer Cell 2008, 13:472-482.
13. Griffin J.L., Shockcor J.P. Metabolic profiles of cancer cells. Nat. Rev. Cancer 2004, 4:551-561.
14. Hanahan D., Weinberg R.A. Hallmarks of cancer: the next generation. Cell 2011, 144:646-674.
15. Brown R.S., Wahl R.L. Overexpression of Glut-1 glucose transporter in human breast cancer. An immunohistochemical study. Cancer 1993, 72:2979-2985.
16. C. Binder, L. Binder, D. Marx, A. Schauer, W. Hiddemann Deregulated simultaneous expression of multiple glucose transporter isoforms in malignant cells and tissues, Anticancer Res. 17 (n.d.) 4299-4304.
17. Krzeslak A., Wojcik-Krowiranda K., Forma E., Jozwiak P., Romanowicz H., Bienkiewicz A., et al. Expression of GLUT1 and GLUT3 glucose transporters in endometrial and breast cancers. Pathol. Oncol. Res. 2012, 18:721-728.
18. Brown R.S., Goodman T.M., Zasadny K.R., Greenson J.K., Wahl R.L. Expression of hexokinase II and Glut-1 in untreated human breast cancer. Nucl. Med. Biol. 2002, 29:443-453.
19. Zhu X., Hart R., Chang M.S., Kim J.-W., Lee S.Y., Cao Y.A., et al. Analysis of the major patterns of B cell gene expression changes in response to short-term stimulation with 33 single ligands. J. Immunol. 2004, 173:7141-7149.
20. Hensley C.T., Wasti A.T., DeBerardinis R.J. Glutamine and cancer: cell biology, physiology, and clinical opportunities. J. Clin. Invest. 2013, 123:3678-3684.
21. Curi R., Newsholme P., Pithon-Curi T.C., Pires-de-Melo M., Garcia C., Homem-de-Bittencourt Júnior P.I., et al. Metabolic fate of glutamine in lymphocytes, macrophages and neutrophils. Braz. J. Med. Biol. Res. 1999, 32:15-21.
22. Mohamed A., Deng X., Khuri F.R., Owonikoko T.K. Altered glutamine metabolism and therapeutic opportunities for lung cancer. Clin. Lung Cancer 2014, 15:7-15.
23. Huang F., Zhao Y., Zhao J., Wu S., Jiang Y., Ma H., et al. Upregulated SLC1A5 promotes cell growth and survival in colorectal cancer. Int. J. Clin. Exp. Pathol. 2014, 7:6006-6014.
24. Fuchs B.C., Bode B.P. Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime?. Semin. Cancer Biol. 2005, 15:254-266.
25. Collins C.L., Wasa M., Souba W.W., Abcouwer S.F. Determinants of glutamine dependence and utilization by normal and tumor-derived breast cell lines. J. Cell. Physiol. 1998, 176:166-178.
26. Kim S., Kim D.H., Jung W.-H., Koo J.S. Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. Endocr. Relat. Cancer 2013, 20:339-348.
27. Elstrom R.L., Bauer D.E., Buzzai M., Karnauskas R., Harris M.H., Plas D.R., et al. Akt stimulates aerobic glycolysis in cancer cells. Cancer Res. 2004, 64:3892-3899.
28. Fan Y., Dickman K.G., Zong W.-X. Akt and c-Myc differentially activate cellular metabolic programs and prime cells to bioenergetic inhibition. J. Biol. Chem. 2010, 285:7324-7333.
29. Robey R.B., Hay N. Is Akt the "Warburg kinase"?-Akt-energy metabolism interactions and oncogenesis. Semin. Cancer Biol. 2009, 19:25-31.
30. Kimmel D.W., Dole W.P., Cliffel D.E. Application of multianalyte microphysiometry to characterize macrophage metabolic responses to oxidized LDL and effects of an apoA-1 mimetic. Biochem. Biophys. Res. Commun. 2013, 431:181-185.
31. Kimmel D.W., Meschievitz M.E., Hiatt L.A., Cliffel D.E. Multianalyte microphysiometry of macrophage responses to phorbol myristate acetate, lipopolysaccharide, and lipoarabinomannan. Electroanalysis 2013, 25:1706-1712.
32. Young C.D., Lewis A.S., Rudolph M.C., Ruehle M.D., Jackman M.R., Yun U.J., et al. Modulation of glucose transporter 1 (GLUT1) expression levels alters mouse mammary tumor cell growth in vitro and in vivo. PLoS ONE 2011, 6:e23205.
33. Barban S., Schulze H.O. The effects of 2-deoxyglucose on the growth and metabolism of cultured human cells. J. Biol. Chem. 1961, 236:1887-1890.
34. Wang J.-B., Erickson J.W., Fuji R., Ramachandran S., Gao P., Dinavahi R., et al. Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 2010, 18:207-219.
35. Koller F.L., Hwang D.G., Dozier E.A., Fingleton B. Epithelial interleukin-4 receptor expression promotes colon tumor growth. Carcinogenesis 2010, 31:1010-1017.
36. Younes M., Brown R.W., Mody D.R., Fernandez L., Laucirica R. GLUT1 expression in human breast carcinoma: correlation with known prognostic markers. Anticancer Res. 1995, 15:2895-2898.
37. Kang S.S., Chun Y.K., Hur M.H., Lee H.K., Kim Y.J., Hong S.R., et al. Clinical significance of glucose transporter 1 (GLUT1) expression in human breast carcinoma. Cancer Sci. 2002, 93:1123-1128.
38. Gaglio D., Metallo C.M., Gameiro P.A., Hiller K., Danna L.S., Balestrieri C., et al. Oncogenic K-Ras decouples glucose and glutamine metabolism to support cancer cell growth. Mol. Syst. Biol. 2011, 7:523.
39. Wise D.R., Thompson C.B. Glutamine addiction: a new therapeutic target in cancer. Trends Biochem. Sci. 2010, 35:427-433.
40. Junttila I.S., Creusot R.J., Moraga I., Bates D.L., Wong M.T., Alonso M.N., et al. Redirecting cell-type specific cytokine responses with engineered interleukin-4 superkines. Nat. Chem. Biol. 2012, 8:990-998.